<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1894">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136508</url>
  </required_header>
  <id_info>
    <org_study_id>4-2021-0401</org_study_id>
    <nct_id>NCT05136508</nct_id>
  </id_info>
  <brief_title>The Effect of Volatile Anesthesia and Total Intravenous Anesthesia on Shedding of the Endothelial Glycocalyx in Patients Undergoing Mastectomy and Breast Reconstruction Using Deep Inferior Epigastric Artery Perforator Free Flap</brief_title>
  <official_title>The Effect of Volatile Anesthesia and Total Intravenous Anesthesia on Shedding of the Endothelial Glycocalyx in Patients Undergoing Mastectomy and Breast Reconstruction Using Deep Inferior Epigastric Artery Perforator Free Flap</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the effects of total intravenous and inhalation&#xD;
      anesthesia on the damage of endothelial glucocorticoids by comparing the concentration of&#xD;
      syndecan-1 in patients undergoing mastectomy and breast reconstruction using deep inferior&#xD;
      epigastric artery perforator free flap&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study was to investigate the effects of total intravenous and inhalation&#xD;
      anesthesia on the damage of endothelial glucocorticoids by comparing the concentration of&#xD;
      syndecan-1 in patients undergoing mastectomy and breast reconstruction using deep inferior&#xD;
      epigastric artery perforator free flap&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 21, 2021</start_date>
  <completion_date type="Actual">November 13, 2021</completion_date>
  <primary_completion_date type="Actual">November 13, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in blood concentration of syndecan-1</measure>
    <time_frame>1) 10 minutes after anesthesia induction &lt;before surgery(base concentration)&gt; 2) 10 minutes after sitting position 3) 1 hour after surgery</time_frame>
    <description>Blood levels of syndecan-1 are assessed at 10 minutes after anesthesia induction, 10 minutes after sitting position, and 1 hour after surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Deep Inferior Epigastric Artery Perforator Flap Breast Reconstruction</condition>
  <arm_group>
    <arm_group_label>TIVA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the TIVA group, anesthesia was induced with TCI of propofol (Ce of 4.0-4.5 μg/ml) and remifentanil (Ce of 4.0 ng/ml). Anesthesia was maintained with TCI of propofol and remifentanil. Anesthesia depth was adjusted to maintain a PSI of 25-50.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inhalation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the volatile group, anesthesia was induced with an intravenous bolus of propofol 1.0-1.5 mg/kg and TCI of remifentanil (effect-site concentration [Ce] of 4.0 ng/ml). Anesthesia was maintained with sevoflurane (0.8-1 age-adjusted minimum alveolar concentration) and TCI of remifentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Anesthesia was induced with TCI of propofol (Ce of 4.0-4.5 μg/ml) and remifentanil (Ce of 4.0 ng/ml). Anesthesia was maintained with TCI of propofol and remifentanil. Anesthesia depth was adjusted to maintain a PSI of 25-50.</description>
    <arm_group_label>TIVA</arm_group_label>
    <other_name>TIVA group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia was induced with an intravenous bolus of propofol 1.5-2 mg/kg and TCI of remifentanil (effect-site concentration [Ce] of 4.0 ng/ml). Anesthesia was maintained with sevoflurane (0.8-1 age-adjusted minimum alveolar concentration) and TCI of remifentanil</description>
    <arm_group_label>Inhalation</arm_group_label>
    <other_name>volatile group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult patients over 20 years old with ASA class I-III&#xD;
&#xD;
          2. Scheduled total mastectomy and deep inferior epigastric artery perforator flap breast&#xD;
             reconstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. emergency surgery&#xD;
&#xD;
          2. Bilateral deep inferior epigastric artery perforator flap breast reconstruction&#xD;
&#xD;
          3. patients unable to make their own decisions, illiterate, foreigners&#xD;
&#xD;
          4. Allergy / hypersensitivity to sevoflurane or propofol 5, Current or past history or&#xD;
             thrombosis / thromboembolism&#xD;
&#xD;
        6. patients who are taking oral contraceptives 7. Patients with renal insufficiency (eGFR&#xD;
        60 ml / min / 1.73 m 2 or less) 8. Patients receiving anticoagulants 9. pregnant and&#xD;
        lactating women 10. Patients with history of psychiatric disease or neurological disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Na Young Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yonsei University Health System, Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 16, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>syndecan-1</keyword>
  <keyword>propofol</keyword>
  <keyword>volatile</keyword>
  <keyword>anesthesia</keyword>
  <keyword>deep inferior epigastric artery perforator flap breast reconstruction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

